Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Apr;33(4):638-42.
doi: 10.3174/ajnr.A2845. Epub 2011 Nov 24.

Interventional stroke therapies in the elderly: are we helping?

N Zeevi  1 , G A Kuchel, N S Lee, I Staff, L D McCullough
Affiliations

Interventional stroke therapies in the elderly: are we helping?

N Zeevi et al. AJNR Am J Neuroradiol. 2012 Apr.

Abstract

Background and purpose: It is unclear whether endovascular therapies for the treatment of AIS are being offered or are safe in older adults. The use and safety of endovascular interventions in patients older than 75 years of age were assessed.

Materials and methods: A retrospective review of patients with AIS 75 years or older (n = 37/1064) was compared with a younger cohort (n = 70/1190) by using an established data base. Admission and discharge NIHSS scores, rates of endovascular treatment, SICH, in-hospital mortality, and the mBI were assessed.

Results: Rates of endovascular treatments were significantly lower in older patients (5.9% in the younger-than-75-year versus 3.5% in the older-than-75-year cohort, P = .007). Stroke severity as measured by the NIHSS score was equivalent in the 2 age groups. The mBI at 12 months was worse in the older patients (mild or no disability in 52% of the younger-than-75-year and 22% in the 75-year-or-older cohort, P = .006). Older patients had higher rates of SICH (9% in younger-than-75-year versus 24% in the 75-year-or-older group, P = .04) and in-hospital mortality (26% in younger-than-75-year versus 46% in the 75-year-or-older group, P = .05).

Conclusions: Patients older than 75 years of age were less likely to receive endovascular treatments. Older patients had higher rates of SICH, disability, and mortality. Prospective randomized trials are needed to determine the criteria for selecting patients most likely to benefit from acute endovascular therapies.

PubMed Disclaimer

References

    1. Tissue plasminogen activator for acute ischemic stroke: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333: 1581–87 - PubMed
    1. Wolpert SM, Bruckmann H, Greenlee R, et al. . Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator: the rt-PA Acute Stroke Study Group. AJNR Am J Neuroradiol 1993;14: 3–13 - PMC - PubMed
    1. Weimar C, Ziegler A, Konig IR, et al. . Predicting functional outcome and survival after acute ischemic stroke. J Neurol 2002;249: 888–95 - PubMed
    1. Tanne D, Gorman MJ, Bates VE, et al. . Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older: the tPA stroke survey experience. Stroke 2000;31: 370–75 - PubMed
    1. Zeevi N, Chhabra J, Silverman IE, et al. . Acute stroke management in the elderly. Cerebrovasc Dis 2007;23: 304–08 - PubMed

Publication types

MeSH terms